BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 15205456)

  • 1. Mechanism of blebbistatin inhibition of myosin II.
    Kovács M; Tóth J; Hetényi C; Málnási-Csizmadia A; Sellers JR
    J Biol Chem; 2004 Aug; 279(34):35557-63. PubMed ID: 15205456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic mechanism of blebbistatin inhibition of nonmuscle myosin IIb.
    Ramamurthy B; Yengo CM; Straight AF; Mitchison TJ; Sweeney HL
    Biochemistry; 2004 Nov; 43(46):14832-9. PubMed ID: 15544354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structural basis of blebbistatin inhibition and specificity for myosin II.
    Allingham JS; Smith R; Rayment I
    Nat Struct Mol Biol; 2005 Apr; 12(4):378-9. PubMed ID: 15750603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blebbistatin stabilizes the helical order of myosin filaments by promoting the switch 2 closed state.
    Zhao FQ; Padrón R; Craig R
    Biophys J; 2008 Oct; 95(7):3322-9. PubMed ID: 18599626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibition of arterial smooth muscle tonic contractions by the selective myosin II inhibitor, blebbistatin.
    Eddinger TJ; Meer DP; Miner AS; Meehl J; Rovner AS; Ratz PH
    J Pharmacol Exp Ther; 2007 Feb; 320(2):865-70. PubMed ID: 17132816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blebbistatin inhibits the chemotaxis of vascular smooth muscle cells by disrupting the myosin II-actin interaction.
    Wang HH; Tanaka H; Qin X; Zhao T; Ye LH; Okagaki T; Katayama T; Nakamura A; Ishikawa R; Thatcher SE; Wright GL; Kohama K
    Am J Physiol Heart Circ Physiol; 2008 May; 294(5):H2060-8. PubMed ID: 18296570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic characterization of the sole nonmuscle myosin-2 from the model organism Drosophila melanogaster.
    Heissler SM; Chinthalapudi K; Sellers JR
    FASEB J; 2015 Apr; 29(4):1456-66. PubMed ID: 25636739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of blebbistatin, an inhibitor of myosin II.
    Limouze J; Straight AF; Mitchison T; Sellers JR
    J Muscle Res Cell Motil; 2004; 25(4-5):337-41. PubMed ID: 15548862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The myosin inhibitor blebbistatin stabilizes the super-relaxed state in skeletal muscle.
    Wilson C; Naber N; Pate E; Cooke R
    Biophys J; 2014 Oct; 107(7):1637-46. PubMed ID: 25296316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the myosin II inhibitory potency of A-ring-modified (S)-blebbistatin analogs.
    Verhasselt S; Stevens CV; Van den Broecke T; Bracke ME; Roman BI
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2986-2989. PubMed ID: 28512027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug specificity and affinity are encoded in the probability of cryptic pocket opening in myosin motor domains.
    Meller A; Lotthammer JM; Smith LG; Novak B; Lee LA; Kuhn CC; Greenberg L; Leinwand LA; Greenberg MJ; Bowman GR
    Elife; 2023 Jan; 12():. PubMed ID: 36705568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. para-Nitroblebbistatin, the non-cytotoxic and photostable myosin II inhibitor.
    Képiró M; Várkuti BH; Végner L; Vörös G; Hegyi G; Varga M; Málnási-Csizmadia A
    Angew Chem Int Ed Engl; 2014 Jul; 53(31):8211-5. PubMed ID: 24954740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myosin II ATPase inhibitor blebbistatin prevents thrombin-induced inhibition of intercellular calcium wave propagation in corneal endothelial cells.
    Ponsaerts R; D'hondt C; Bultynck G; Srinivas SP; Vereecke J; Himpens B
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4816-27. PubMed ID: 18614806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for a novel, strongly bound acto-S1 complex carrying ADP and phosphate stabilized in the G680V mutant of Dictyostelium myosin II.
    Uyeda TQ; Tokuraku K; Kaseda K; Webb MR; Patterson B
    Biochemistry; 2002 Jul; 41(30):9525-34. PubMed ID: 12135375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myosin complexed with ADP and blebbistatin reversibly adopts a conformation resembling the start point of the working stroke.
    Takács B; Billington N; Gyimesi M; Kintses B; Málnási-Csizmadia A; Knight PJ; Kovács M
    Proc Natl Acad Sci U S A; 2010 Apr; 107(15):6799-804. PubMed ID: 20351242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of nucleotide binding to actomyosin VI: evidence for allosteric head-head communication.
    Robblee JP; Olivares AO; de la Cruz EM
    J Biol Chem; 2004 Sep; 279(37):38608-17. PubMed ID: 15247304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blebbistatin, a myosin II inhibitor, suppresses contraction and disrupts contractile filaments organization of skinned taenia cecum from guinea pig.
    Watanabe M; Yumoto M; Tanaka H; Wang HH; Katayama T; Yoshiyama S; Black J; Thatcher SE; Kohama K
    Am J Physiol Cell Physiol; 2010 May; 298(5):C1118-26. PubMed ID: 20164381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of Phe472 with a fluorescent inhibitor bound to the complex of myosin subfragment-1 with nucleotide.
    Hiratsuka T
    Biochemistry; 2006 Jan; 45(4):1234-41. PubMed ID: 16430219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blebbistatin, a novel inhibitor of myosin II ATPase activity, increases aqueous humor outflow facility in perfused enucleated porcine eyes.
    Zhang M; Rao PV
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4130-8. PubMed ID: 16249490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and Computational Insights into a Blebbistatin-Bound Myosin•ADP Complex with Characteristics of an ADP-Release Conformation along the Two-Step Myosin Power Stoke.
    Ewert W; Franz P; Tsiavaliaris G; Preller M
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.